StockNews.com Downgrades MediWound (NASDAQ:MDWD) to Sell

MediWound (NASDAQ:MDWDGet Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.

Separately, HC Wainwright reiterated a “buy” rating and set a $28.00 price target on shares of MediWound in a report on Friday, March 22nd.

Check Out Our Latest Stock Analysis on MediWound

MediWound Stock Down 5.6 %

Shares of MDWD stock opened at $14.25 on Friday. The stock has a market cap of $135.23 million, a P/E ratio of -18.51 and a beta of 0.94. MediWound has a 52 week low of $7.10 and a 52 week high of $17.25. The company’s fifty day simple moving average is $14.04 and its two-hundred day simple moving average is $11.15.

Institutional Investors Weigh In On MediWound

Several hedge funds have recently modified their holdings of MDWD. PNC Financial Services Group Inc. acquired a new stake in MediWound in the fourth quarter valued at approximately $57,000. Pathstone Holdings LLC purchased a new position in shares of MediWound during the fourth quarter worth $111,000. MGO One Seven LLC acquired a new stake in MediWound during the 4th quarter worth about $124,000. BlackRock Inc. raised its position in MediWound by 122.6% during the second quarter. BlackRock Inc. now owns 15,238 shares of the biopharmaceutical company’s stock valued at $162,000 after acquiring an additional 8,392 shares in the last quarter. Finally, Citadel Advisors LLC purchased a new position in MediWound during the fourth quarter valued at approximately $170,000. Hedge funds and other institutional investors own 46.83% of the company’s stock.

MediWound Company Profile

(Get Free Report)

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.

Featured Stories

Receive News & Ratings for MediWound Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediWound and related companies with MarketBeat.com's FREE daily email newsletter.